Estimating Treatment Effect With Clinical Interpretation From a Comparative Clinical Trial With an End Point Subject to Competing Risks.
Where this comes from
- Record sourced from PubMed, PMID 29541747.
- Also identified by DOI 10.1001/jamacardio.2018.0127 and PMC identifier 5875301.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study explores using the restricted mean time lost to quantify treatment effects from cardiovascular therapy.
Medical subject headings
- Adrenergic beta-Antagonists
- Cardiovascular Diseases
- Data Interpretation, Statistical
- Propanolamines